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A B S T R A C T
Objective: To evaluate and compare the quality of life (QOL) of patients undergoing esophagectomy for treatment of adenocarcinoma
of the esophagogastric junction and squamous cell carcinoma. Methods: We conducted a cross-sectional study in postoperative
patients submitted to  esophagectomy for adenocarcinoma of the esophagogastric junction (ACA) and squamous cell carcinoma
(SCC), using the SF-36 questionnaire applied in 24 patients (10 ACAs and 14 SCCs), from the 5th months postoperatively, including
clinical symptoms and weight change. Results: The assessment of QOL showed the best functional capacity (p = 0.018) in the ACA
group. There was a correlation between the domains “mental health” and “Role of Emotions” (p = 0.003) and between “pain” and
“physical aspects limitation” (p = 0.003) in both histological types. Weight loss was greater in ACA (45.9 kg), with no significant
difference between current BMI (p> 0.66). Dysphagia was reported by 83.3% of patients, anorexia by58.3%, chewing difficulty by
42%, nausea and vomiting by 41.7% and diarrhea by 29.2%, with no correlation with QOL reported (p> 0.05). Conclusion: The
highest score for functional capacity indicates that ACA patients were able to perform all types of physical activity, including the more
demanding, at a higher level than patients with SCC. Some symptoms persisted postoperatively, but did not affect the quality of life
of patients.
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INTRODUCTION
Squamous cell carcinoma cell carcinoma (SCC) used to be the main focus of attention of the studies on
esophageal cancer1. However, increased incidence of
adenocarcinoma of the esophagogastric junction (Adenoca)
has been reported in the last four decades2.
The SCC is strongly correlated with smoking and
alcohol consumption, and the adenocarcinoma of the
esophagogastric junction is associated with Barrett’s
esophagus and gastroesophageal reflux3. Evidence suggests
that obesity is positively associated with risk of developing
esophageal Adenoca, while malnutrition has been linked
to SCC4.
There are comparative analysis of the quality of
life of patients submitted to esophagectomy according to
some surgical aspects, such as comparing the limited trans-
hiatal resection to extensive transthoracic resection5;
between reconstruction with gastric tube and interposing
the colon6; comparison between curative esophagectomy
and palliation7,8; or even the comparison between the
domains of quality of life with symptoms (physical and
emotional) and factors related to illness and operation9.
We did not found in the literature the possible differences
between the quality of life of patients submitted to
esophagectomy for Adenoca of the esophagogastric
junction and the one of those submitted to esophagectomy
by SCC.
De Boer et al. compared the quality of life of
patients undergoing esophagectomy for Adenoca three
years after trans-hiatal or transthoracic resection5.
Moreover, Rosmolen et al., in a longitudinal study,
analyzed the quality of life among survivors of long periods8
(minimum two years) after resection and reconstruction
with transmediastinal gastric tube in 100 patients, also in
patients with Adenoca. De Boer et al., in another longitu-
dinal study, included 67% of Adenoca in the total sample
studied and 28% of SCC9.
In the first six months after surgery, during a
variable period of time the patient experiences undesirable
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symptoms, such as low food intake, nausea, ongoing weight
loss, feeling of weakness, diarrhea, dysphagia and pain10,
and a quality of life that can be greatly impaired, returning
to preoperative levels7,11. Thus, once it is possible to better
evaluate and investigate these symptoms, they can certainly
be minimized through guidelines and treatments, improving
the quality of life of the patient.
The objective of this study was to evaluate and
compare the quality of life of patients submitted to
esophagectomy for adenocarcinoma of the esophagogastric
junction and squamous cell carcinoma, from the fifth month
postoperatively, using the generic SF-36, and to investigate
weight variations, the presence of dysphagia, anorexia,
nausea, vomiting, diarrhea and constipation and relate them
to quality of life.
METHODS
We performed transversal analyses of 24 patients
undergoing esophagectomy from September 2004 to
August 2008, due to cancer of the esophagus or cardia,
from the fifth postoperative month. The operations were
performed by the Group of Esophagus, Stomach and
Duodenum Surgery of the Clinics Hospital of the Faculty of
Medical Sciences, University of Campinas (UNICAMP),
according to the standardized transmediastinal technique,
followed by esophagogastroplasty with gastric tube, cervical
esophagogastric anastomosis, pyloromyotomy and feeding
jejunostomy in all cases.
This research was developed to meet the
requirements of Resolution MS/CNS No 196 of October 10th,
1996, and was approved by the Ethics and Research
Committee of FCM-UNICAMP, with Protocol 505/2003 on
20/07/2004.
As inclusion criteria, we selected patients who
were not undergoing chemo or radiotherapy and had no
metastasis at the time of the study. No patient had
verbalizing or memory difficulty to answer questions and
all agreed to sign an Informed Consent Informed.
We did not include patients submitted to
esophagectomy for benign disease, in the immediate
postoperative period or in less than five months, bedridden
and those who could not attend the clinic for evaluations.
Patients were asked, via social worker, to attend
to the clinic on the date established to respond to the SF-
36 questionnaire and physical examination, and recording
of medical history, socio-economic and cultural data and
clinical symptoms.
The data analyzed were age, sex, marital status,
race, education, histological type, time elapsed between the
operation and the interview, weight and height to calculate
body mass index (BMI) obtained in balance platform, with
the individual barefoot and wearing light clothing. The results
of BMI were assessed according to the World Health
Organization12 for adults and to Lipschitz13 for elders.
Weight loss was calculated by analyzing the
percentage of adequacy between the regular or usual
weight of the patient before the operation and the current.
The presence of dysphagia, difficulty chewing, anorexia,
nausea, vomiting, diarrhea and constipation were
investigated during the interview with the patient.
The quality of life was assessed by the
questionnaire “Medical Outcomes Study 36-Item Short Form
Health Survey” (SF-36) used in clinical practice in general,
in research, evaluation of health policies and population
analyzes to measure general quality of life. This
questionnaire was developed by Ware and Sherbourne14
and translated into Portuguese and validated by Ciconelli
et al.15.
The SF-36 consists of 11 sections with sub-items
totaling 36 questions spread across eight domains. These
areas are grouped into two major components: physical
and mental.
The physical component involves the domains
functional capacity, role physical aspects, pain and general
health, while the mental component comprises the domains
mental health, vitality, emotional and social aspects. The
results obtained are compared with those of Aaronson et
al.16.
The results from the SF-36 questionnaire of quality
of life indicate better results when closer to 100 and worse
outcomes when closer to zero.
Due to the characteristics of the disease, the
sample size was established according to the availability
of patients in the period studied, the occurrence of death,
loss to follow-up and reflection on the practical aspects,
such as time constraints and statistical issues. We used
the absolute (n) and relative (%) frequencies for nomi-
nal qualitative variables, and the mean and standard
deviation for quantitative variables and to describe the
values found.
The Student t test was applied to the study of
mean BMI of each histological type and to comparisons of
the results obtained in the domains “Pain”, “General
Health” and “Mental Health”, and the Mann-Whitney test
for domains “Functional Capacity”, “Limitation due to
physical aspects”, “vitality”, “Social Aspects” and
“Limitation due to Emotional Aspects”.
The search for association between the time
elapsed after the operation until the interview and the
results of the assessment of quality of life was performed
by Pearson correlation test. Furthermore, it was assessed
whether the time elapsed from operation until the interview
influenced the results of the quality of life of patients
interviewed. The comparison between the mean obtained
for each histological type was performed by the Mann-
Whitney test.
The testes of association of anorexia, dysphagia,
nausea/vomiting, bowel habits and the histological type
were performed by Fisher’s test. Significance was
considered if “p” was less than 0.05.
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RESULTS
The 24 study participants were mostly men
(91.7%), Caucasian (70.8%), married (83.3%), mean age
58.8 years, minimum 44 and maximum 83 years . It is
worth noting that 37.5% were elderly, or older than 60
years. Regarding education, the mean for this sample was
4.9 years studied (Table 1).
Patients eligible for the study were divided into
two groups according to histological type: Adenoca (n =
10) and SCC (n = 14). All patients were evaluated with a
minimum of five months postoperatively and a maximum
of eight years, 11 months and four days. The mean
postoperative time for survey participants was two years,
four months and 26 days and, according to histological type,
in cases of Adenoca the average time was one year, eight
months and five days, and for SCC, two years, ten months
and 31 days. However, this difference in time between the
two histological types was not significant (p = 0.8168).
The distribution of variables “quality of life” and
“time elapsed from operation” can be seen in figure 1.
Table 2 shows the values   of the components of
the SF-36 scores obtained and related to the time elapsed
from operation.
The average percentage of weight loss (Table 3)
was higher among patients with Adenoca (16.84%).
However, the mean current BMI for the Adenoca group
was 21.5 (SD 2.7) and in the SCC group it was 21.0 (SD-2,
8), without significant difference between the results (p =
0 , 6602).
When comparing the quality of life of both
histological types of esophageal cancer, there was no
significant difference in the domain “Functional Capacity”,
and all other areas were equal.
By analyzing the responses collected in the eight
components of the SF-36 that were presented in Table 4, it
can be said that there is a difference between the two
histological types for the domain “Functional Capacity” (p
= 0.017) and that for all other domains, equality cannot be
rejected, and in the domains “Pain”, “vitality”, “Mental
Health” and “Limitation due to Emotional Aspects”, there
is strong evidence for equality between the histological
types.
The result obtained in the domain “Social
Aspects” shows an average slightly different between
the two histological types, but not considered significant
(p = 0.2570), the same happening to “General Health”
(p = 0.3591 ), “Limitation due to Physical Aspects” (p =
0.3614) and “Limitation due to Emotional Aspects” (p =
0.7317).
The domains “Limitations by Emotional Aspects”
and “Limitation due to Physical Aspects” have the highest
standard deviation among all categories, with the average
component “Limitation due to Emotional Aspects” 20 points
higher than the average of the variable “Limitation due to
Physical Aspects”.
Correlation analysis between the variable “Men-
tal Health” and “Limitation due to Emotional Aspects” has
resulted in ñ = 0.587, with a p-value of 0.003, and a strong
evidence that there is a relationship between the two
variables. Similar results were obtained in the variables
“Limitation due to Physical Aspects” and “Pain”, (ñ = 0.586,
p=0.003). In addition, when analyzing the correlation of
these variables between patients with Adenoca and SCC
separately, the correlation was even greater.
The results obtained from the 24 patients studied
after administration of the SF-36 are included in Table 4.
Statistical analysis using the Fisher exact test showed no
statistically significant differences in the pain domain (p =
0.032) for the group Adenoca and functional capacity (p =
0.003), Limitation due to physical aspects (p = 0.027) and
in social aspects (p = 0.0468) for the SCC group.
The analysis of clinical data shows that there was
no association between dysphagia, anorexia, nausea,
vomiting, diarrhea and constipation and histological type
(Table 5). Dysphagia was reported by 83.3% of patients
and remains a major postoperative symptom, followed by
anorexia (58.3%), nausea and vomiting (41.7%) and
diarrhea (29.2%).
Other symptoms not related to postoperative
esophagectomy were investigated and displayed
percentages close to 42% for difficulty chewing and 25%
for constipation.
Table 1 - Characteristics of the sample of patients
studied.





< 60 15 (62.5)
60 - 69 4  (16.7)
70 a 83 5  (20.8)
Race
Caucasian 17  (70.8)
Non-caucasian 7  (29.2)
Tumor Histological Type
Adenocarcinoma of Esophagus or Cardia 10 (41.7)
Squamous Cell Carcinoma 14 (58.3)
Marital Status
Married 20  (83.4)
Single/ divorced 4  (16.6)
Educat ion
Iliterate 2  (8.3)
Up to 4 years 11  (45.8)
Up to 7 years 3  (12.5)
More than 7 years 1  (4.17)
College graduation 1 ( 4.17)
Not informed 6  (25)
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DISCUSSION
The focus of this study was to compare the quality
of life of patients submitted to esophagectomy for two
histological types of esophageal cancer: the Adenoca of
esophagus or cardia and SCC. The increasing frequency of
Adenoca justifies this concern17-20. Another issue to consider
is the most pronounced increase in survival of patients with
esophageal Adenoca when compared to patients with SCC,
according to a study conducted in Sweden in the nineties21.
The SF-36 has been validated and used worldwide to
evaluate patients with benign and malignant diseases, pre and
Table 2 - Mean, standard deviation, minimum and maximum values of the results of the SF-36 scores according to the histological
type and the elapsed time from the operation.
Adenocarcinoma (n = 10) Squamous Cell Carcinoma (n = 14)
Domain m e a n s t anda rd median minimum maximum m e a n standard median minimum maximum p value
dev ia t ion dev ia t ion
Functional Capacity 80.5 11.9 80.0 60.0 100.0 58.6 28.1 67.5 10.0 95.0 0.017
Limitation due to Physical Aspects 57.5 39.2 62.5 0.0 100.0 41.1 41.2 25.0 0.0 100.0 0.3614
Pain 54.5 21.6 61.5 10.0 84.0 57.1 28.1 62.0 20.0 100.0 0.8056*
General Health Status 58.4 21.5 53.5 35.0 100.0 65.8 17.1 64.5 25.0 97.0 0.3591*
Vitality 64.0 17.9 67.5 30.0 90.0 65.4 15.0 65.0 30.0 95.0 1.0000
Social Aspects 81.3 17.9 87.5 50.0 100.0 65.2 30.7 68.8 12.5 100.0 0.2570
Limitation due to Emotional 73.4 34.4 83.4 0.0 100.0 64.3 42.3 83.4 0.0 100.0 0.7317
Aspects
Mental Health 61.6 20.9 60.0 24.0 92.0 64.0 25.2 68.0 16.0 96.0 0.8076*
Time after operation in months 19.2 20.4 10.4 5.6 64.0 33.4 43.6 11.9 5.0 132.0 0.8168
Mann-Whitney test/ * Student’s t test.
Figure 1 - Correlation between the variables of quality of life and time elapsed from the operation until the interview.
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postoperatively14,15,22. And it was very useful in this population,
since 79% of interviewed patients had some degree of functional
illiteracy. The use of a visual scale that could be used in these
situations to corroborate the results presented would contribute
to obtain information more easily. Moreover, since it is a trans-
versal study, during the research inevitable deaths occurred; this
difficulty was also reported by other authors8.
The strong point of this study was to compare
our results with the data presented by Aaronson et al.16 for
a healthy Netherlands population, demonstrating significant
differences in the pain domain (p = 0.032) for the Adenoca
group, and functional capacity (p = 0.003), Limitation due
to physical aspects (p = 0.027) and social aspects (p =
0.0468) for the SCC group.
Table 3 - Changes in weight after esophagectomy.
 Porcentage Mean Minimum (Kg) Maximum (Kg)
Adenoca 16.84% -0.7 45.9
SCC 8.54% -2 22.9
Total 12.00% -2 45.9
Table 4 - SF-36 of 24 patients (58.8 years) compared to those of Aaronson et al.16 in a healthy population (41-60
years).
Va r i ab l e T o t a l p value Adeno - p value Ca epidermoid p value Aaronsonet al.16
sample study ca r c inoma samp le
Functional Capacity 67.71 (sd 24.98) 0.003 80.5 (sd 11.89) 0.473 58.57 (sd 28.11) 0.0033 84.0 (sd 19.6)
Limitation due to Physical Aspects 47.92 (sd 40.32) 0.023 57.5 (39.2) 0.5430 41.1 (sd 41.1) 0.0270 74.5 (sd 36.8)
Pain* 56.04 (sd 25.10) 0.005 54.5 (21.58) 0.0320 57.14 (28.09) 0.0728 71.8 (sd 24.1)
General Health Status 62.71 (sd 19.00) 0.046 58.4 (sd 21.51) 0.188 65.79 (sd 17.14) 0.2329 69.7 (sd 20.6)
Vitality 64.79 (sd 15.91) 0.371 64 (sd 17.92) 0.5410 65.36 (sd 15) 0.4517 68.6 (sd 20.2)
Social Aspects 71.88 (sd 26.90) 0.056 81.25 (sd 17.92) 0.731 65.18 (sd 15) 0.0468 83.5 (sd 22.1)
Limitation due to Emotional 68.07 (sd 38.66) 0.735 73.4 (sd 34.4) 0.844 64.3 (sd 42.3) 0.5161 81.6 (sd 33.2)
Aspects
Mental Health* 63 (sd 23.03) 0.013 61.6 (sd 20.93) 0.064 64 (sd 25.15) 0.1081 75.6 (sd 18.5)
Mann-Whitney test/ * Student’s t test
Table 5 - Association of anorexia, dysphagia, nausea / vomiting and bowel habits with histological type.
TOTAL Adenocarcinoma Squamous Cell Carcinoma p value
n % n % n %
Anorexia 0.6785
absent 10 41 .7 5 50 .0 5 35 .7
present 14 58 .3 5 50 .0 9 64 .3
Dysphagia 0.2721
absent 4 16 .7 3 30 .0 1 7 .1
present 20 83 .3 7 70 .0 13 92 .9
Chewing 0.2112
Good 14 58 .3 4 40 .0 10 71 .4
Bad 10 41 .7 6 60 .0 4 28 .6
Nausea/Vomit ing 0.2112
absent 14 58 .3 4 40 .0 10 71 .4
present 10 41 .7 6 60 .0 4 28 .6
Bowel Habit 0.0713
constipation 6 25 .0 5 50 .0 1 7 .1
diarrhea 7 29 .2 2 20 .0 5 35 .7
normal 11 45 .8 3 30 .0 8 57 .1
Fisher’s exact test (p> 0.05)
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The quality of life of patients with Adenoca
showed similar results with the healthy population,
according to research from De Boer et al.9, with the
exception of pain domain, which differed from the healthy
population. Zieren et al.23 demonstrated that the quality of
life of patients undergoing esophagectomy for SCC proved
to be hampered by physical limitations.
In this research, the lowest scores were found in
“Limitation due to Physical Aspects” and “Limitation due to
Emotional Aspects”. The lowest scores in these areas mean
that the patients had problems with work or other daily activity
depending on their physical and emotional health. These
considerations were confirmed by the correlation found
between the domains “Mental Health” and “Limitation due
to Emotional Aspects” and “Limitation due to Physical
Aspects” and “Pain” for all patients in general and also
according to the histological type. And the best result for the
histological type Adenoca in the domain “Functional
Capacity” suggests that these patients are more likely than
the others to perform all kinds of physical activities, including
the most vigorous ones. Moreover, considering that the
average of component “Limitation due to Emotional Aspects”
was 20 points higher than the average of the variable
“Limitation due to Physical Aspects”, we can conclude that,
after esophagectomy, the patient’s physical condition is a
greater difficulty than the psychological one.
The analysis of quality of life of patients in this
study, in different transversal points (from five months to
more than eight years after surgery) did not show to have
been influenced by time, ie there was not a relationship of
dependence between them. These results are in agreement
with the prospective study of Djärv et al., who included
patients submitted to esophagectomy between six months
and three years, with no difference in quality of life related
to health after the operation24.
The dispersion analysis (Figure 1) between the
variables quality of life and the elapsed time after surgery
until the time of the interview also showed no statistical
difference (p> 0.05), therefore not influencing the final
results of the research. However, we believe that this result
should be interpreted with caution due to the small sample
and because quality of life is a subjective and
multidimensional measure, results needing to be validated
in a larger sample.
No association was found between quality of life
and dysphagia, difficulty in chewing, anorexia, nausea,
vomiting, diarrhea and constipation, although these data
have been reported in both histological types. The difficulty
in chewing reported by 42% of patients may be due to the
presence of elderly in 37% of the sample, for whom the
adequacy of dental prostheses and oral health could
minimize the problems reported.
Although esophagectomy for esophageal cancer
has a high operative morbidity, it is considered the standard
treatment for patients with resectable tumors without clinical
contraindications3,25. Knowing the quality of life of the patient
and the points at which it can be improved will certainly
help the patient and the healthcare team to decide the best
treatment and how to face this new phase of life.
It is essential that patients undergoing
esophagectomy receive postoperative behavioral and dietary
counseling as part of their overall treatment. In this sense,
the participation of a multidisciplinary team composed of
nutritionists, physiotherapists and psychologists can help
patients in their recovery. The role of the family in this
confrontation contributed greatly according to the
observations of Steinglass et al.26 in their survey on quality
of life in oncology, emphasizing the need to develop tools
for family assessment.
In conclusion, this study showed better functional
capacity in the Adenoca group when compared to the SCC
group and equality between them in the other areas of
assessment of quality of life. A comparison of these groups
with a healthy population showed equality of life between
healthy people and the Adenoca group, except for pain
and worse outcomes for functional capacity when the
healthy group is compared to the SCC group. Patients in
both groups suffered from dysphagia, anorexia, difficulty
chewing, nausea, vomiting, diarrhea and constipation, which
were not related to quality of life.
R E S U M O
Objetivo: Avaliar e comparar a qualidade de vida de pacientes esofagectomizados para tratamento de adenocarcinoma da junção
esofagogástrica e de carcinoma epidermoide.  Métodos: estudo transversal no pós-operatório de doentes esofagectomizados por
adenocarcinoma da junção esofagogástrica (Adenoca)  e carcinoma epidermóide (CEC), empregando o questionário SF-36 aplicado
em 24 pacientes (10 por Adenoca e 14 por CEC), a partir do 5º mês de pós-operatório, incluindo os sintomas clínicos e a variação de
peso. Resultados: A avaliação da QV mostrou melhor resultado de capacidade funcional (p=0,018) para o grupo Adenoca. Houve
correlação entre os domínios “saúde mental” e “limitação por aspectos emocionais” (p=0,003) e entre “dor” e “limitação por
aspectos físicos” (p=0,003) nos dois tipos histológicos. A perda de peso foi maior nos esofagectomizados por Adenoca (45,9Kg), sem
diferença significativa entre o IMC atual (p>0,66). A disfagia foi relatada por 83,3% dos pacientes, a anorexia por 58,3%, a
dificuldade de mastigação por 42%, a náuseas e os vômitos por 41,7% e a diarréia por 29,2%, sem correlação com a QV relatada
(p>0,05). Conclusão: O escore mais alto para capacidade funcional indica que o paciente com Adenoca foi capaz de realizar todo
tipo de atividade física, incluindo as mais vigorosas em um nível maior que o paciente com CEC.  Alguns sintomas persistiram no pós-
operatório, porém não interferiram na qualidade de vida dos pacientes.
Descritores: Adenocarcinoma. Carcinoma de células escamosas. Qualidade de vida. Esofagectomia. Transtornos de deglutição.
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